Evidence map›Paper›PMID 42002631›Full record

ReviewWorld journal of urology2026

A molecular landscape tracking the progression of non-muscle invasive bladder cancer.

Giuseppe Cesta, Cinzia Zolfanelli, Vincenzo Lauciello, Vincenzo Lorusso, Ferdinando Di Giacomo, Pellegrino Mazzone, Teresa D'Amore, Giuseppina Di Paola, Daniele Bravoco, Geppino Falco and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giuseppe Cesta *Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Cinzia Zolfanelli *Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Vincenzo LaucielloLaboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Vincenzo LorussoDepartment of Urology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Ferdinando Di GiacomoDepartment of Urology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Pellegrino MazzoneBiogem S.c.a.r.l., Istituto Di Ricerche Genetiche 'Gaetano Salvatore', Avellino (AV), 83031, Ariano Irpino, Italy.
Teresa D'AmoreLaboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB).
Giuseppina Di PaolaBiogem S.c.a.r.l., Istituto Di Ricerche Genetiche 'Gaetano Salvatore', Avellino (AV), 83031, Ariano Irpino, Italy.
Daniele BravocoBiogem S.c.a.r.l., Istituto Di Ricerche Genetiche 'Gaetano Salvatore', Avellino (AV), 83031, Ariano Irpino, Italy.
Geppino Falco *Department of Biology, University of Naples Federico II, 80147, Naples, Italy.
Claudia Sabato *Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), . claudia.sabato@crob.it.ORCID http://orcid.org/0000-0001-7533-4660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersBladder cancerBladder progressionGene signatureNon-muscle-invasive bladder cancer

Identifiers

PMID42002631
PMCPMC13092541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.